the 15th BioEquity Europe meeting / Gene Signal will attend the 15th BioEquity Europe meeting taking place in Amsterdam from May 21-22nd 2014
JP Morgan's 32nd Annual Healthcare Conference / Gene Signal's CEO, Eric Viaud to attend JP Morgan's 32nd Annual Healthcare Conference to be held January 13-16th in San Francisco, California
Gene Signal present at BIOEurope 2012 in Hamburg, Germany
Gene Signal will be present at BIO-Europe,® Europe's largest partnering conference, serving the global biotechnology industry. The conference annually attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging companies.
ISER 2012 (International Society for Eye Research), 20th Biennial Meeting / July 21-25th 2012, Berlin, Germany
Gene Signal reports that following topical delivery of a single 86 μg dose, bioactive levels of aganirsen are achieved in the retina, and that retinal delivery is likely to occur via the trans-scleral route.
ARVO Eye Research Conference 2012 / Gene Signal unveils latest PK data at ARVO’s “Drug and Gene Delivery to the Back of the Eye” Congress in Denver, Colorado.
Data demonstrates that bioactive levels of Aganirsen are achieved in the retina following topical delivery of a single 86-μg dose
2012 ARVO Annual Meeting / Fort Lauderdale, Fla. Topical Aganirsen will be discussed at a breakfast roundtable due to take place during ARVO 2012, the world's largest gathering of international eye and vision researchers
J.P. MORGAN HEALTHCARE CONFERENCE / Eric Viaud, CEO, presents at the 30th Annual J.P. Morgan Healthcare Conference held J at the Westin St. Francisco, in San Francisco, CA, USA.
ILSI BIO MED 2011 / Eric Viaud, CEO presents at ILSI BioMed 2011, the 10th National Life Science & Technology Week in Israel (Tel Aviv, May 23-25 2011).
UBS 2010 GLOBAL LIFE SCIENCE CONFERENCE / Gene Signal presents at the UBS 2010 Global Life Science conference being held September 20 - 22, 2010, at The Grand Hyatt New York in New York, NY.
ANNUAL MEETING OF THE AAO (AMERICAN ACADEMY OF OPHTHALMOLOGY) / Gene Signal presents data on Aganirsen in Corneal Neovascularisation associated with Graft Rejection
ANNUAL MEETING OF DOG (OF THE GERMAN OPHTHALMIC SOCIETY) / Gene Signal presents data on Aganirsen in Corneal Neovascularisation associated with Graft Rejection
85TH CONGRESS SEO (SPANISH SOCIETY OF OPHTHALMOLOGY / Gene Signal presents compassionate use experience
XXVII CONGRESS OF ESCRS (EUROPEAN SOCIETY OF CATARACT AND REFRACTORY SURGERY) / Gene Signal presents first data in cornea
102ND CONGRESS OF SOG-SSO (SWISS SOCIETY OF OPHTHALMOLOGY) / Gene Signal presents first data in cornea
17TH CONGRESS OF SOE (PAN EUROPEAN SOCIETY OF OPHTHALMOLOGY) / Gene Signal presents first data in cornea
115 EME CONGRÈS DE LA SOCIÉTÉ FRANÇAISE D'OPHTALMOLOGIE (SFO) / Gene Signal presents first data in cornea
2009 ANNUALMEETING OF ARVO / Gene Signal poster session